An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
about
Pivotal roles of GM-CSF in autoimmunity and inflammationPulmonary alveolar proteinosisA New Scale to Assess the Severity and Prognosis of Pulmonary Alveolar ProteinosisGM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative NeoplasmDistinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic DiseasesNocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis.Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report.Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort studyRituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.Whole Lung Lavage Treatment of Chinese Patients with Autoimmune Pulmonary Alveolar Proteinosis: A Retrospective Long-term Follow-up Study.Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis.Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis.Pulmonary alveolar proteinosis: Experience from a tertiary care center and systematic review of Indian literature.Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges.Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013.Pulmonary alveolar proteinosis: report of two cases in the West of Ireland with review of current literature.Pulmonary alveolar proteinosis: time to shift?Metabolic and storage lung diseases: spectrum of imaging appearances.Lung disease: Treatment by cell transplant.Rituximab for auto-immune alveolar proteinosis, a real life cohort study.
P2860
Q26830824-D996872D-85B5-47B8-B13F-8FB4E82465DFQ28387156-A1F57604-E01D-4D06-9112-84901E097341Q28388126-90552D5A-AE93-429C-A6D5-71485D6B59D0Q29248620-DA4B35C3-E84F-47AD-AA42-DF22C590F54BQ33563703-75E94ED8-AA30-4694-9BD0-95C05E2A9402Q35197274-665003F4-A71B-4866-94A2-407D2A047592Q35624741-1098F2CC-D563-457A-A715-224B0C77D6CDQ35743143-3BC2D1C3-B2CC-46FD-8545-47B337B7A40FQ36204781-7546E626-3C8A-4BB6-A11F-CB600C9D7FA2Q36531842-AFBEDEA0-46AF-46C0-8148-ACBB1BC0FA24Q36910316-A56FD99E-24F5-442D-B760-3F8DFA92E32BQ37072048-8C88DE8E-08F9-48D5-9C35-44A8061C358BQ37362027-8D15ACC8-E52B-46C5-9727-5D29A86AACABQ37419630-201DDDBB-A7ED-4756-8C42-4B7A9881A3FDQ38041659-FE374321-DCF7-4929-B955-919C789FE3EBQ38049370-AD1FFC9F-B4D8-4AA0-9BBF-688B9BEED94CQ38113188-9DE2AAC3-C6F0-486E-9157-D9DFF5D50676Q38416755-BB77BCB6-A5F7-49D9-89B5-35CCA43B9914Q41815300-FD3662A7-B003-48F1-B674-648FA92F4B9CQ48026318-CFBBB7DD-3544-46E3-A240-E0EC2D79D1E0Q55239888-E571B695-3605-4F0E-BA99-541D83E79C0B
P2860
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
@en
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
@nl
type
label
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
@en
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
@nl
prefLabel
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
@en
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
@nl
P2093
P2860
P1476
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
@en
P2093
H Dalrymple
I Marshall
M J Thomassen
M S Kavuru
R Karnekar
P2860
P304
P356
10.1183/09031936.00197710
P577
2011-04-08T00:00:00Z